THE GLYCOSAMINOGLYCAN COMPOSITION OF THE LUNG WITH ACUTE AND CHRONIC PATHOLOGY AND IN SENESCENCE

被引:4
作者
GRUNDBOECKJUSCO, J
BINETTE, JP
KIMURA, A
TALARICO, L
KAELIN, R
SCHMID, K
机构
[1] VET ADM MED CTR, DEPT MED, 151, 3495 BAILEY AVE, BUFFALO, NY 14215 USA
[2] BOSTON UNIV, ZENT INST, DEPT BIOCHEM, BOSTON, MA 02118 USA
[3] BOSTON UNIV, MED CTR, DEPT MED, DIV HEMATOL, BOSTON, MA 02118 USA
[4] BOSTON UNIV, MED CTR, CTR PULM, BOSTON, MA 02118 USA
[5] SUNY BUFFALO, SCH MED, BUFFALO, NY 14214 USA
关键词
GLYCOSAMINOGLYCAN; ANATOMIC COMPONENTS; HUMAN LUNG; PNEUMOCONIOSIS; PNEUMONIA; SENESCENCE;
D O I
10.1016/0009-8981(92)90023-J
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The content and distribution of GAGs in the anatomic structures of patholgical (pneumoconiosis, pneumonia, pulmonary embolism) and senescent lungs have been measured. The total GAG content of the lung structures, except central bronchi is generally lower than normal in the pathological lungs. The GAG distribution in the pleura (DS predominant), central bronchi (C6S predominant), arteries, veins and `total lung' is similar to the corresponding normal distribution. The other notable observations are: the concentration of HA in peripheral bronchi and alveoli is increased possibly in response to the high local concentration of coal dust; an age related GAG switch from DS in the arteries of the young to C6S in the arteries of the mature lung is confirmed; the arterial GAG content generally increases with age up to age 103 in the male; the arteries of a female smoker display the mature male pattern of GAG composition. The data suggest that gender, smoking and age, more than acute pathology, determine the GAG composition of the anatomic structures of the lung.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 21 条
[1]  
BLACKWOOD RA, 1983, P SOC EXP BIOL MED, V174, P343
[2]  
CANTOR JO, 1980, P SOC EXP BIOL MED, V164, P1
[3]  
CANTOR JO, 1983, P SOC EXP BIOL MED, V174, P172
[4]  
DEGAND P, 1972, Revue de Tuberculose et de Pneumologie, V36, P119
[5]  
Green F H, 1980, Pathol Annu, V15, P333
[6]  
HATAE Y, 1977, GANN, V68, P59
[7]  
HORAI T, 1981, CANCER, V48, P2016, DOI 10.1002/1097-0142(19811101)48:9<2016::AID-CNCR2820480918>3.0.CO
[8]  
2-A
[9]   GLYCOSAMINOGLYCANS - MOLECULAR-PROPERTIES, PROTEIN INTERACTIONS, AND ROLE IN PHYSIOLOGICAL PROCESSES [J].
JACKSON, RL ;
BUSCH, SJ ;
CARDIN, AD .
PHYSIOLOGICAL REVIEWS, 1991, 71 (02) :481-539
[10]  
KARLINSKY J, 1983, J LAB CLIN MED, V102, P151